Friday 4 October / 10.15-11.45
AF & HF: recent advances in therapy
J. Brachmann / Coburg, Germany
A. Proclemer / Udine, Italy
- Prevalence and significance of AF in HF with reduced and preserved EF
R Gopinathannair / Overland Park, USA
- Medical drug therapy: which role today?
Capucci / Ancona, Italy
- After AATAC and CASTLE-AF, should AF catheter ablation be labeled as class I indication?
M.G. Chelu / Salt Lake City, USA
- Biventricular/HB pace-and-ablate: when, who, and why?
M. Grimaldi / Acquaviva delle Fonti, Italy